Prevent Cancer Foundation welcomes 2025 corporate members advancing cancer prevention and early detection
即时发布
Audrey Kashatus
703-836-3687
audrey.kashatus@preventcancer.org
Alexandria, Va. – The Prevent Cancer Foundation® proudly welcomes its largest-ever cohort—16 leading companies—as 2025 members of the Corporate Membership Program. These organizations join a growing community dedicated to advancing cancer prevention and early detection nationwide.
“In just two years, our Corporate Membership Program has grown into a thriving community of partners dedicated to cancer prevention and early detection,” said Jody Hoyos, CEO of the Prevent Cancer Foundation. “These corporate partners share our commitment to saving lives, and by collaborating with industry leaders, we’re reaching more people and helping them take charge of their health.”
The 2025 class of corporate members, as of the date of this publication, include:
Silver members
- 精确科学
- Hologic
- Ipsen
- 辉瑞
- 美国药物研究与制造商协会
Bronze members
- AstraZeneca
- AVEO Oncology
- Amgen
- BMS
- 卫材
- 基因泰克
- Geneoscopy
- 守护者
- Lilly
- 默克
- Natera
- Sanofi
Through the Corporate Membership Program, business leaders help expand the Foundation’s reach and impact. Members participate in Foundation events, including industry roundtables, to collaborate and exchange ideas throughout the year. Membership supports the Foundation’s work in four key areas: research, education, outreach and advocacy.
The Corporate Membership Program is open to companies who share the Foundation’s vision of a world where cancer is preventable, detectable and beatable for all. To learn more or inquire about joining, contact Jennifer Niyangoda, Vice President of Development and Marketing, at jennifer.niyangoda@preventcancer.org.
###
About the Prevent Cancer Foundation®
The Prevent Cancer Foundation® is the only U.S.-based nonprofit organization solely dedicated to cancer prevention and early detection. Through research, education, outreach and advocacy, we have helped countless people avoid a cancer diagnosis or detect their cancer early enough to be successfully treated. We are driven by a vision of a world where cancer is preventable, detectable and beatable for all.
基金会正奋起应对到 2035 年将癌症死亡人数减少 40% 的挑战。为实现这一目标，我们承诺投资 $2000 万美元用于创新技术，以早期发现癌症并推进多癌筛查，投资 $1000 万美元用于扩大医疗服务不足社区的癌症筛查和疫苗接种机会，并投资 $1000 万美元用于教育公众有关筛查和疫苗接种的选择。
For more information, please visit www.preventcancer.org.